ScholarIQanswers from OpenAlex

Primary intrathoracic liposarcoma: a clinicopathologic study and prognostic analysis of 23 cases

PaperCitations, authors & open-access status

Primary intrathoracic liposarcoma: a clinicopathologic study and prognostic analysis of 23 cases is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Primary intrathoracic liposarcoma: a clinicopathologic study and prognostic analysis of 23 cases have?

ScholarIQcitation count

Primary intrathoracic liposarcoma: a clinicopathologic study and prognostic analysis of 23 cases has 77 citations in the OpenAlex counts ScholarIQ stores.

When was Primary intrathoracic liposarcoma: a clinicopathologic study and prognostic analysis of 23 cases published?

ScholarIQyear

Primary intrathoracic liposarcoma: a clinicopathologic study and prognostic analysis of 23 cases has 2014 year in the ScholarIQ index.

What is the open-access status of Primary intrathoracic liposarcoma: a clinicopathologic study and prognostic analysis of 23 cases?

ScholarIQoa status

Primary intrathoracic liposarcoma: a clinicopathologic study and prognostic analysis of 23 cases has gold oa status in the ScholarIQ index.

What is the DOI of Primary intrathoracic liposarcoma: a clinicopathologic study and prognostic analysis of 23 cases?

ScholarIQdoi

The DOI for Primary intrathoracic liposarcoma: a clinicopathologic study and prognostic analysis of 23 cases is on the source record.

What is the PMID of Primary intrathoracic liposarcoma: a clinicopathologic study and prognostic analysis of 23 cases?

ScholarIQpmid

The PMID for Primary intrathoracic liposarcoma: a clinicopathologic study and prognostic analysis of 23 cases is on the source record.

What is the OpenAlex record for Primary intrathoracic liposarcoma: a clinicopathologic study and prognostic analysis of 23 cases?

ScholarIQopenalex

The OpenAlex for Primary intrathoracic liposarcoma: a clinicopathologic study and prognostic analysis of 23 cases is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial